Today's Stocks Driving Success For The Health Services Industry

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 73 points (0.5%) at 14,495 as of Friday, March 22, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,725 issues advancing vs. 1,132 declining with 170 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is up 0.6%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.9%, Fresenius Medical Care Corporation ( FMS), up 1.2% and Covidien ( COV), up 0.5%. On the negative front, top decliners within the industry include Agilent Technologies ( A), down 1.3%, Express Scripts ( ESRX), down 0.9% and Thermo Fisher Scientific ( TMO), down 0.6%.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Zimmer Holdings ( ZMH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Zimmer Holdings is up $0.59 (0.8%) to $72.97 on light volume Thus far, 339,514 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $72.35-$73.20 after having opened the day at $72.56 as compared to the previous trading day's close of $72.38.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $12.4 billion and is part of the health care sector. Currently there are 12 analysts that rate Zimmer Holdings a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Zimmer Holdings Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Zimmer Biomet's Prognosis Is Promising

Zimmer Biomet's Prognosis Is Promising

St. Jude Buying Thoratec Could Resusitate Medtech M&As

Analysts' Actions -- AT&T, Fitbit, Netflix and More

Barbarian At The Gate: Zimmer Holdings (ZMH)

Deal Delay Minor Obstacle for Zimmer

Deal Delay Minor Obstacle for Zimmer